J. Christopher Naftzger

Officer, Unilife Corp.

Companies

Arbutus BiopharmaGeneral counsel Jul 12, 2023 to Feb 19, 2025¹
Nabriva Therapeutics plcGeneral counsel Sep 15, 2021 to Aug 15, 2022²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Arbutus Biopharma ABUS140,544 shares³$602.2K at $4.29Feb 14, 2025
Nabriva Therapeutics plc7,000 shares⁴Dec 27, 2021

As of each latest filing. The line shows shares held over time.

Recent filings

Feb 14, 2025Granted 54,300 shares of Arbutus Biopharma³
Feb 4, 2025Sold 11,333 shares at $3.28 of Arbutus Biopharma⁵
Feb 1, 2024Granted 95,100 shares of Arbutus Biopharma⁶
Dec 27, 2021Bought 7,000 shares at $0.59 of Nabriva Therapeutics plc⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARArbutus Biopharma, General counsel
2
SEC EDGARNabriva Therapeutics plc, General counsel
3
SEC EDGARArbutus Biopharma shares after the filing of Feb 14, 2025
4
SEC EDGARNabriva Therapeutics plc shares after the filing of Dec 27, 2021
5
SEC EDGARForm 4 filed Feb 5, 2025
6
SEC EDGARForm 4 filed Feb 5, 2024